Back


12/09/2018
ImCheck Therapeutics Appoints Prof. René Hoet, PhD, as Chief Scientific Officer
ImCheck Therapeutics, an emerging biopharmaceutical company developing novel immune modulators against cancer and auto-immune diseases, announced today the appointment of René Hoet, PhD, as its Chief Scientific Officer. René Hoet is a molecular immunologist with over 20 years’ experience in antibody discovery and development. Over the course of his career, he has held leadership positions in antibody discovery and development at Bayer, Genmab, and Dyax. [...]

Download the pdf file





X

X